EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii

Robyn Manley, Christian Fitch, Vanessa Francis, Isaac Temperton, Dann Turner, Julie Fletcher, Mitchelmore Phil, Steve Michell, Ben Temperton

Journal of Medical Microbiology · 2024

DOI: 10.1099/jmm.0.001829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2024. Verfasst von Robyn Manley und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Exeter, Health and Life Sciences, Streatham Campus, Exeter, EX4 4QD, UK. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Bacteriophages, Acinetobacter Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, GW4 BIOMED MRC DTP, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acinetobacter baumannii is a critical priority pathogen for novel antimicrobials (World Health Organization) because of the rise in nosocomial infections and its ability to evolve resistance to last resort antibiotics. A. baumannii is thus a priority target for phage therapeutics. Two strains of a novel, virulent bacteriophage (LemonAid and Tonic) able to infect carbapenem-resistant A. baumannii (strain NCTC 13420), were isolated from environmental water samples collected through a citizen science programme. Gap statement. Phage-host coevolution can lead to emergence of host resistance, with a concomitant reduction in the virulence of host bacteria; a potential benefit to phage therapy applications. Methodology. In vitro and in vivo assays, genomics and microscopy techniques were used to characterize the phages; determine mechanisms and impact of phage resistance on host virulence, and the efficacy of the phages against A. baumannii .

Results

A. baumannii developed resistance to both viruses, LemonAid and Tonic. Resistance came at a cost to virulence, with the resistant variants causing significantly reduced mortality in a Galleria mellonella larval in vivo model. A replicated 8 bp insertion increased in frequency (~40 % higher frequency than in the wild-type) within phage-resistant A. baumannii mutants, putatively resulting in early truncation of a protein of unknown function. Evidence from comparative genomics and an adsorption assay suggests this protein acts as a novel phage receptor site in A. baumannii . We find no evidence linking resistance to changes in capsule structure, a known virulence factor. LemonAid efficiently suppressed growth of A. baumanni in vitro across a wide range of titres. However, in vivo , while survival of A. baumannii infected larvae significantly increased with both remedial and prophylactic treatment with LemonAid (10 7 p.f.u. ml –1 ), the effect was weak and not sufficient to save larvae from morbidity and mortality.

Conclusion

While LemonAid and Tonic did not prove effective as a treatment in a Galleria larvae model, there is potential to harness their ability to attenuate virulence in drug-resistant A. baumannii .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiBacteriophagesAcinetobacter InfectionsVirulenceAnimalsMothsPhage TherapyAnti-Bacterial AgentsDrug Resistance, BacterialLarva

Stichwörter der Autor:innen

Acinetobacter baumanniiGalleria mellonellalyticphage resistancevirulence

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • University of Exeter, Health and Life Sciences, Streatham Campus, Exeter, EX4 4QD, UK.
  • School of Applied Sciences, College of Health, Science and Society, University of the West of England, Bristol, Frenchay Campus, Coldharbour Lane, Bristol, BS16 1QY, UK.
  • University of Exeter, College of Medicine and Health, Department of Respiratory Medicine, Royal Devon & Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK.

Förderung

  • Wellcome Trust
  • GW4 BIOMED MRC DTP
  • Medical Research Council
  • Wellcome

Zitieren

APA

Manley, R., Fitch, C., Francis, V., Temperton, I., Turner, D., Fletcher, J., Phil, M., Michell, S., & Temperton, B. (2024). Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001829

Vancouver

Manley R, Fitch C, Francis V, Temperton I, Turner D, Fletcher J, et al. Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii. Journal of Medical Microbiology. 2024. doi:10.1099/jmm.0.001829

BibTeX
@article{Manley2024,
  author = {Manley, Robyn and Fitch, Christian and Francis, Vanessa and Temperton, Isaac and Turner, Dann and Fletcher, Julie and Phil, Mitchelmore and Michell, Steve and Temperton, Ben},
  title = {Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii},
  journal = {Journal of Medical Microbiology},
  year = {2024},
  doi = {10.1099/jmm.0.001829}
}
Kostenlos starten →